Previous 10 | Next 10 |
Investment Thesis Last week, in my research note on direct Trillium (TRIL) rival, Forty Seven (FTSV), I argued that Forty Seven was the pick of the immunology companies developing CD47 antibodies to treat various forms of cancer - including hematologic malignancies, diffuse large B-cell ly...
Gainers: Neurotrope (NASDAQ: NTRP ) +126% . More news on: Neurotrope, Inc., Genprex, Inc., Trillium Therapeutics Inc., Stocks on the move, , Read more ...
One Stop Systems (NASDAQ: OSS ) +56% reports prelim results . More news on: One Stop Systems, Inc., Genprex, Inc., Akcea Therapeutics, Inc., Stocks on the move, Read more ...
Forty Seven Inc. (FTSV) had achieved positive results from an early-stage study in treatment-naive patients with high-risk myelodysplastic syndrome ((MDS)) and acute myeloid leukemia ((AML)). The positive results were obtained using the company's drug magrolimab in combination with Vidaza (a...
CAMBRIDGE, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that the Compa...
Gainers: Cemtrex (NASDAQ: CETX ) +100% . More news on: Cemtrex, Inc., OrganiGram Holdings Inc., Fluent, Inc., Stocks on the move, , Read more ...
RTI Surgical Holdings (NASDAQ: RTIX ) +105% on sale of OEM business . More news on: RTI Surgical Holdings, Inc., TransEnterix, Inc., XBiotech Inc., Stocks on the move, , Read more ...
Penny stocks are some of the most unique in the market. The biggest reason has to do with the ability to move unassociated with the direction of the stock market. Now, this isn’t always the case. But there’s a good chance that even if the broad stock market is tanking, there are ...
Sorrento Therapeutics (NASDAQ: SRNE ) +50% on non-binding takeover bid . More news on: Sorrento Therapeutics, Inc., Aclaris Therapeutics, Inc., AzurRx BioPharma, Inc., Stocks on the move, Read more ...
Gainers: Trillium Therapeutics (NASDAQ: TRIL ) +106% . More news on: Trillium Therapeutics Inc., Applied Genetic Technologies Corporation, Genetic Technologies Limited, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...